Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus

Current Gene Therapy

Volumn 4, Issue 4, 2004, Pages 385-408

  Oehmig, Angelika ^a   Fraefel, Cornel ^b   Breakefield, Xandra O ^a   Ackermann, Mathias ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adeno associated virus; Amplicon; Epstein Barr virus; Herpes simplex virus type 1; Hybrid amplicon; Retrovirus; Vector systems

Indexed keywords

CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; CRE RECOMBINASE; DNA; GAG PROTEIN; GLYCOPROTEIN B; GLYCOPROTEIN D; HELICASE; LATENCY ASSOCIATED NUCLEAR ANTIGEN; MESSENGER RNA; PARVOVIRUS VECTOR; POL PROTEIN; PROTEIN C; PROTEIN P53; RECOMBINASE; RETROVIRUS VECTOR; SOMATOMEDIN B RECEPTOR; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

AMPLICON; BACTERIOPHAGE; CELL DIVISION; CELL NUCLEUS; CELL POPULATION; CELL TYPE; CHROMOSOME; DILUTION; DNA MODIFICATION; DNA VECTOR; EPISOME; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE INSERTION; GENE SEQUENCE; GENE TARGETING; GENETIC CONSERVATION; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; MOLECULAR SIZE; NONHUMAN; PROTEIN FAMILY; PROTEIN TRANSPORT; REVIEW; TRANSCRIPTION REGULATION; TRANSGENE; TRANSPOSON; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS HYBRID; VIRUS INFECTION; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 4; SIMPLEXVIRUS; UNIDENTIFIED BACTERIOPHAGE; UNIDENTIFIED RETROVIRUS;

EID: 8844245604     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523043346129     Document Type: Review

References (222)

1. Akkina, R.K., Walton, R.M., Chen, M.L., Li, Q.X., Planelles, V. and Chen, I.S. (1996) High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitits virus envelope glycoprotein G. J Virol, 70: 2581-2585.
2. Albritton, L. M., Tseng, L., Scadden, D. and Cunningham, J. M. (1989) A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell, 57: 659-666.
3. Anderson, D.B., Laquerre, S., Ghosh, K., Ghosh, H.P., Goins, W.F., Cohen, J.B. and Glorioso, J.C. (2000) Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J Virol, 74: 2481-2487.
4. Avitabile, E., Di Gaeta, S., Torrisi, M.R., Ward, P.L., Roizman, B. and Campadelli-Fiume, G. (1995) Redistribution of microtubules and Golgi apparatus in herpes simplex virus-infected cells and their role in viral exocytosis. J Virol., 69: 7472-7482.
5. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Seguin, C., Tuffnell, P. S., Barrell, B.G. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature, 310 207-211.
6. Bakowska, J.C., Di Maria M.V., Camp, S.H., Wang, Y., Allen, P.D. and Breakefield, X.O. (2003). Targeted transgene integration into transgenic mouse fibroblasts carrying full-length human AAVSI locus mediated by HSV/AAV rep(+) hybrid amplicon vector. Gene Ther., 19:1691-1702.
7. Balague, C., Kalla, M. and Zhang, W.W. (1997). Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol., 71: 3299-3306.
8. Ban, J., Hlavaty, J., Orlik, O., Splitter, G. A. and Altaner, C. (1999) The human homologue of the bovine leukemia virus receptor BLVRcp1 is the delta-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51. Arch. Virol., 144: 2013 -2022.
9. Banerjee, S., Livanos, E. and Vos, J.M. (1995) Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus. Nat Med., 1 1303-8.
10. Bates, P., Young, J. A. and Varmus, H. E. (1993) A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell, 74: 1043-1051.
11. Bearer, E.L., Breakefield, X.O., Schuback, D., Reese, T.S. and LaVail, J.H. (2000) Retrograde axonal transport of herpes simplex virus: Evidence for a single mechanism and a role for tegument. Proc Natl Acad Sci USA, 97: 8146-8150.
12. Beaufils, P., Choquet, D., Mamoun, R. Z. and Malissen, B. (1993) The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J., 12: 5105-5112.
13. Berns, K.I. (1996). Parvoviridae: the viruses and their replication. In: Fields Virology, Fields, B.N., Knipe, D.M. and Howley, P.M. (Eds), Lippincott-Raven, Philadelphia, Pa., Vol. 3, pp. 2173-2197.
14. Bloom, D.C., Hill, J.M., Devi-Rao, G., Wagner, E.K., Feldman, L.T. and Stevens, J.G. (1996) A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J. Virol., 70: 2449-2459.
15. Bodescot, M., Perricaudet, M. and Farrell, P. J. (1987) A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. J. Virol., 61:3424-3430.
16. Boviatsis, E.J., Park, J.S., Sena-Esteves, M., Kramm, C.M., Chase, M., Efird, J.T., Wei, M.X., Breakefield, X.O. and Chiocca, E.A. (1994a). Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res., 54: 5745-5751.
17. Boviatsis, E.J., Scharf, J.M., Chase, M., Harrington, K., Kowall, N.W., Breakefield, X.O. and Chiocca, E.A. (1994b). Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. Gene Ther., 1: 323-331.
18. Brojatsch, J., Naughton, J., Rolls, M. M., Zingler, K. and Young, J. A. (1996) CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell, 87: 845-855.
19. Brunetti, C.R., Dingwell, K.S., Wale, C., Graham, F.L. and Johnson, D.C. (1998) Herpes simplex virus gD and virions accumulate in endosomes by mannose 6-phosphate-dependent and -independent mechanisms. J. Virol., 72: 3330-3339.
20. Cai, W., Gu, B. and Person, S. (1988). Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol., 62: 2596-2604.
21. Campadelli, G., Brandimarti, R., Di Lazzaro, C., Ward, P.L., Roizman, B. and Torrisi, M.R. (1993) Fragmentation and dispersal of Golgi proteins and redistribution of glycoproteins and glycolipids processed through the Golgi apparatus after infection with herpes simplex virus 1. Proc.Natl.Acad.Sci. USA., 90: 2798-2802.
22. Campadelli-Fiume, G., Stirpe, D., Boscaro, A., Avitabile, E., Foa-Tomasi, L., Barker, D. and Roizman, B. (1990). Glycoprotein C dependent attachment of herpes simplex virus to susceptible cells leading to productive infection. Virology, 178: 213-222.
23. Carel, J. C., Myones, B. L., Frazier, B. and Holers, V. M. (1990) Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. Biol. Chem., 265: 12293-12299.
24. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J. and Sergeant, A. (1986) Both Epstein-Barr virus (EBV)-encoded transacting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J., 5: 3243-3249.
25. Coffin, R.S., MacLean, A.R., Latchman, D.S. and Brown, S.M. (1996). Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther., 3 886-891.
26. Cone, R.D. and Mulligan, R.C. (1984) High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc. Natl. Acad. Sci. USA 81: 6349-6353.
27. Conway, J.E., Rhys, C.M., Zolotukhin, I., Zolotukhin, S., Muzyczka, N., Hayward, G.S. and Byrne, B.J. (1999). High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther., 6: 986-993.
28. Cooke, H. (2001) Mammalian artificial chromosomes as vectors: progress and prospects. Cloning Stem Cells, 3: 243-249.
29. Costantini, L.C., Jacoby, D.R., Wang, S., Fraefel, C., Breakefield, X.O., and Isacson O. (1999). Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Hum. Gene Ther., 10: 2481-2494.
30. Cox, M. A., Leahy, J. and Hardwick, J. M. (1990) An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol., 64 313-321.
31. Danos, O. and Mulligan, R.C. (1988) Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA, 85: 6460-6464.
32. de Felipe, P., Izquierdo, M., Wandosell, F. and Lim, F. (2001) Integrating retroviral cassette extends gene delivery of HSV-1 expression vectors to dividing cells. Biotechniques, 31: 394-402, 404-405.
33. Deiss, L.P., Chou, J. and Frenkel, N. (1986). Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus. J. Virol., 59: 605-618.
34. De Larco, J. E., Rapp, U. R. and Todaro, G. J. (1978) Cell surface receptors for ecotropic MuLV: detection and tissue distributions of free receptors in vivo. Int. J. Cancer, 21: 356-360.
35. Delecluse, H.J., Hilsendegen, T., Pich, D., Zeidler, R. and Hammerschmidt, W. (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. USA, 95: 8245-8250.
36. Delecluse, H.J., Pich, D., Hilsendegen, T., Baum, C. and Hammerschmidt, W. (1999) A first-generation packaging cell line for Epstein-Barr virus-derived vectors. Proc. Natl. Acad. Sci. USA, 96: 5188-5193.
37. Desai, P.G., Schaffer, P.A. and Minson, A.C. (1988). Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J. Gen. Virol., 69 1147-1156.
38. Desai, P., DeLuca, N.A. and Person, S. (1998) Herpes simplex virus type 1 VP26 is not essential for replication in cell culture but influences production of infectious virus in the nervous system of infected mice. Virology, 247: 115-124.
39. Dilber, M.S., Phelan, A., Aints, A., Mohamed, A.J., Elliott, G., Edvard Smith, C.I. and O'Hare, P. (1999) Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther., 6: 12-21.
40. Dingwell, K.S., Brunetti, C.R., Hendricks, R.L., Tang, Q., Tang, M., Rainbow, A.J. and Johnson, D.C. (1994) Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J. Virol., 68: 834-845.
41. Dingwell, K.S., Doering, L.C. and Johnson, D.C. (1995) Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J. Virol., 69: 7087-7098.
42. Dingwell, K.S. and Johnson, D.C. (1998) The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J. Virol., 72: 8933-8942.
43. Dolyniuk, M., Wolff, E. and Kieff, E. (1976) Proteins of Epstein-Barr Virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus. J. Virol., 18: 289-297.
44. During, M.J., Naegele, J.R., O'Malley, K.L. and Geller, A.I. (1994). Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science, 266: 1399-1403.
45. Dyall, J. and Berns, K.I. (1998). Site-specific integration of adeno-associated virus into an episome with the target locus via a deletion-substitution mechanism. J. Virol., 72: 6195-6198.
46. Edinger, A. L., Hoffman, T. L., Sharron, M., Lee, B., Yi, Y., Choe, W., Kolson, D. L., Mitrovic, B., Zhou, Y., Faulds, D., Collman, R. G., Hesselgesser, J., Horuk, R. and Doms, R. W. (1998) An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol., 72: 7934-7940.
47. Elliott, G. and O'Hare, P. (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell, 88: 223-233.
48. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science, 272 872-877.
49. Feudner, E., de Alwis, M., Thrasher, A.J., Ali, R.R. and Fauser, S. (2001). Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system. J. Virol. Methods, 96: 97-105.
50. Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N. and Minson, T. (1992). Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J. Virol., 66: 341-348.
51. Fraefel, C., Song, S., Lim, F., Lang, P., Yu, L., Wang, Y., Wild, P. and Geller, A.I. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol., 70: 7190-7.
52. Fraefel, C., Jacoby, D.R., Lage, C., Hilderbrand, H., Chou, J.Y., Alt, F.W., Breakefield, X.O. and Majzoub, J.A. (1997) Gene transfer into hepatocytes mediated by helper virus free HSV/AAV hybrid vectors. Mol. Med., 3: 813-825.
53. Frech, B., Zimber-Strobl, U., Suentzenich, K. O., Pavlish, O., Lenoir, G. M., Bornkamm, G. W. and Mueller-Lantzsch, N. (1990) Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human sera. J. Virol., 64: 2759-2767.
54. Freundlieb, S., Schirra-Muller, C. and Bujard, H. (1999) A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J. Gene Medicine, 1: 4-12.
55. Fruh, K., Ahn, K., Djaballah, H., Sempe, P., van Endert, P.M., Tampe, R., Peterson, P.A. and Yang, Y. (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature, 375: 415-418.
56. Fujiwara, T. and Mizuuchi, K. (1988) Retroviral DNA integration: structure of an integration intermediate. Cell, 54 497-504.
57. Geller, A.I. and Breakefield, X.O. (1988). A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science, 241: 1667-1669.
58. Geller, A.I., Keyomarski, K., Bryan, J. and Pardee, A.B. (1990). An efficient deletion mutant packaging system for defective HSV-1 vectors; potential applications to neuronal physiology and human gene therapy. Proc. Natl. Acad. Sci. USA, 87: 8950-8954.
59. Geraghty, R.J., Krummenacher, C., Cohen, G.H., Eisenberg, R.J. and Spear, P.G. (1998). Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280: 1618-1620.
60. Giraud, C., Winocour, E. and Berns, K. I. (1994). Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc. Natl. Acad. Sci. USA, 91: 10039-10043.
61. Glorioso, J.C. and Fink, D.J. (2002). Use of HSV vectors to modify the nervous system. Curr. Opin. Drug Discov. Devel., 5 289-295.
62. Goff, S.P. (2001) Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways. J. Gene Med., 3: 517-528.
63. Goss, J.R., Goins, W.F., Lacomis, D., Mata, M., Glorioso, J.C. and Fink, D.J. (2002). Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes, 51: 2227-2232.
64. Grandi, P., Wang, S., Schuback, D., Krasnykh, V., Spear, H., Curiel, D.T., Manservigi, R., Breakefield, X.O. (2004). HSV-I virions engineered for specific binding to cell surface receptors. Mol. Ther. 3:419-427.
65. Grimm, D., Kern, A., Rittner, K. and Kleinschmidt, J.A. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther., 9: 2745-2760.
66. Hammerschmidt, W. and Sugden, B. (1988) Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell, 55:427-433.
67. Heister, T., Heid, I., Ackermann, M. and Fraefel, C. (2002) Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19. J. Virol., 76: 7163-7173.
68. Herold, B.C., WuDunn, D., Soltys, N. and Spear, P.G. (1991). Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol., 65: 1090-1098.
69. Herrlinger, U., Woiciechowski, C., Sena-Esteves, M., Aboody, K.S., Jacobs, A.H., Rainov, N.G., Snyder, E.Y. and Breakefield, X.O. (2000). Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol. Ther., 1: 347-357.
70. Hilkens, J., Colombatti, A., Strand, M., Nichols, E., Ruddle, F. H. and Hilgers, J. (1979) Identification of a mouse gene required for binding of Rauscher MuLV envelope gp70. Somatic Cell Genet., 5 39-49.
71. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H. and Johnson, D. (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature, 375: 411-415.
72. Hill, J.M., Garza, H.H.J., Su, Y.H., Meegalla, R., Hanna, L.A., Loutsch, J.M., Thompson, H.W., Varnell, E.D., Bloom, D.C. and Block, T.M. (1997) A 437-base-pair deletion at the beginning of the latency-associated transcript promoter significantly reduced adrenergically induced herpes simplex virus type 1 ocular reactivation in latently infected rabbits. J. Virol., 71: 6555-6559.
73. Hillenberg, M., Tonnies, H. and Strauss, M. (2001) Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer. J. Virol., 75: 9896-9908.
74. Ho, D.Y. and Mocarski, E.S. (1989) Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc.Natl.Acad.Sci. USA, 86: 7596-7600.
75. Ho, D.Y., Saydam, T.C., Fink, S.L., Lawrence, M.S. and Sapolsky, R.M. (1995). Defective herpes virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults. J. Neurochem., 65: 842-850.
76. Hocknell, P.K., Wiley, R.D., Wang, X., Evans, T.G., Bowers, W.J., Hanke, T., Federoff, H.J. and Dewhurst, S. (2002). Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses. J. Virol., 76: 5565-5580.
77. Horsburgh, B.C., Hubinette, M.M., Qiang, D.M., MacDonald, L. and Tufaro, F. (1999). Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther. 6: 922-930.
78. Hu, J., Garber, A.C. and Renne, R. (2002) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol., 76: 11677-11687.
79. Hunter, E., Casey, J., Hahn, B., Hayami, M., Korber, B., Kurth, R., Neil, J., Rethwilm, A., Sonigo, P., Stoye, J. (2000). Family Retroviridae. In: Van Regenmortel, M.H.V., Fauquet, C.M., Bishop, D.H.L., Carstens, E.B., Estes, M.K., Lemon, S.M., Maniloff, J., Mayo, M.A., McGeoch, D.J., Pringle C.R. and Wickner, R.B. (Eds.), Virus Taxonomy, Academic Press, San Diego, pp. 369-387.
80. Ichikawa, T., Hogemann, D., Saeki, Y., Tyminski, E., Terada, K., Weissleder, R., Chiocca, E.A. and Basilion, J.P. (2002) MRI of transgene expression: correlation of therapeutic gene expression. Neoplasia, 4: 523-530.
81. Isobe, M., Huebner, K., Maddon, P. J., Littman, D. R., Axel, R. and Croce, C. M. (1986) The gene encoding the T-cell surface protein T4 is located on human chromosome 12. Proc. Natl. Acad. Sci. USA, 83: 4399-4402.
82. Ivics, Z., Hackett, P.B., Plasterk, R.H. and Izsvak, Z. (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell, 91: 501-510.
83. Jacob, R.J. and Roizman, B. (1977) Anatomy of herpes simplex virus DNA. VIII. Properties of the replicating DNA. J. Virol., 23: 394-411.
84. Jacobs, A., Voges, J., Reszka, R., Lercher, M., Gossmann, A., Kracht, L., Kaestle, C., Wagner, R., Wienhard, K. and Heiss, W.D. (2001) Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet, 358: 727-729.
85. Jacobs, A.H., Winkeler, A., Hartung, M., Slack, M., Dittmar, C., Kummer, C., Knoess, C., Galldiks, N., Vollmar, S., Wienhard, K. and Heiss, W.D. (2003) Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Hum. Gene Ther., 14: 277-297.
86. Jamieson, A.T. and Subak-Sharpe, J.H. (1974) Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity. J. Gen. Virol., 24: 481-492.
87. Jerome, K.R., Tait, J.F., Koelle, D.M. and Corey, L. (1998) Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J. Virol., 72: 436-441.
88. Johnson, P.A., Miyanohara, A., Levine, F., Cahill, T. and Friedman, T. (1992). Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol., 66: 2952-2965.
89. Johnston, K.M., Jacoby, D., Pechan, P., Fraefel, C., Borghesani, P., Schuback, D., Dunn, R., Smith, F. and Breakefield, X.O. (1997) HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum Gene Ther, 8: 359-370.
90. Kaludov, N., Brown, K.E., Walters, R.W., Zabner, J. and Chiorini, J.A. (2001). Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75: 6884-6893.
91. Kay, M.A., Glorioso, J. and Naldini, L. (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nature, 7: 33-40.
92. Kaye, K.M., Izumi, K.M. and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad Sci. USA, 90: 9150-9154.
93. Kieff, E. and Rickinson, A.B. (2001) Epstein-Barr virus and its replication. In: Fields Virology, Knipe, D.M. and Howley, P.M. (Eds), Lippincott-Raven, Philadelphia, Pa., 4th edition, pp 2511-2573.
94. Kissa, K., Mordelet, E., Soudais, C., Kremer, E.J., Demeneix, B.A., Brulet, P. and Coen, L. (2002) In vivo neuronal tracing with GFP-TTC gene delivery. Mol Cell Neurosci, 20: 627-637.
95. Koelle, D.M., Tigges, M.A., Burke, R.L., Symington, F.W., Riddell, S.R., Abbo, H. and Corey, L. (1993) Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J.Clin.Invest., 91: 961-968.
96. Kotin, R.M., Siniscalco, M., Samulski, R.J., Zhu, X.D., Hunter, L., Laughlin, C.A., McLaughlin, S., Muzyczka, N., Rocchi, M. and Berns, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad Sci. USA, 87: 2211-2215.
97. Kotin, R.M., Linden, R.M. and Berns, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J, 11: 5071-5078.
98. Lam, P., Hui, K.M., Wang, Y., Allen, P.D., Louis, D.M., Yuan, C.J. and Breakefield, X.O. (2002). Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplican vectors. Hum. Gene Ther., 18:2147-2159.
99. Laquerre, S. anderson, D.B., Stolz, D.B. and Glorioso, J.C. (1998) Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. J. Virol, 72 9683-9697.
100. Laquerre, S., Argnani, R. anderson, D.B., Zucchini, S., Manservigi, R. and Glorioso, J.C. (1998). Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol., 72: 6119-6130.
101. Laughlin, C.A., Tratschin, J-D., Coon, H. and Carter, B.J. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene, 23: 65-73.
102. Lawrence, J. B., Singer, R. H. and Marselle, L. M. (1989) Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization. Cell, 57: 493-502.
103. Li, J., Samulski, R.J. and Xiao, X. (1997) Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol, 71: 5236-5243.
104. Li, Q., Turk, S. M. and Hutt-Fletcher, L. M. (1995) The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol., 69: 3987-3994.
105. Li, Z. and Murthy, V.N. (2001) Visualizing postendocytic traffic of synaptic vesicles at hippocampal synapses. Neuron, 31 593-605.
106. Liebowitz, D., Kopan, R., Fuchs, E., Sample, J. and Kieff, E. (1987) An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol. Cell Biol., 7: 2299-2308.
107. Ligas, M.W. and Johnson, D.C. (1988). A herpes simplex virus mutant in which glycoprotein D sequences are replaced by β -galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62: 1486-1494.
108. Lim, F., Hartley, D., Starr, P., Lang, P., Song, S., Yu, L., Wang, Y. and Geller, A.I. (1996). Generation of high-titer defective HSV-1 vectors using an IE2 deletion mutant and quantitative study of expression in cultured cortical cells. BioTechniques, 20: 458-469.
109. Linden, R.M., Ward, P., Giraud, C., Winocour, E. and Berns, K.I. (1996a). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA, 93: 11288-11294.
110. Linden, R.M., Winocour, E. and Berns, K.I. (1996b). The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA, 93: 7966-7972.
111. Lockshon, D. and Galloway, D.A. (1986). Cloning and characterization of OriL2, a large palindromic replication origin of herpes simplex virus type 2. J. Virol., 58: 513-521.
112. Logvinoff, C. and Epstein, A.L. (2000) Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase. Virology, 267: 102-110.
113. Logvinoff, C. and Epstein, A.L. (2001). A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus. Hum. Gene Ther. 12: 161-167.
114. Longnecker, R. and Kieff, E. (1990) A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J. Virol., 64: 2319-2326.
115. Loudon, P.T., Blakeley, D.M., Boursnell, M.E., Day, D.A., Duncan, I.A., Lowden, R.C., McLean, C.S., Martin, G., Miller, J.C. and Shaw, M.L. (2001). Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients. J. Gene Med., 3: 458-467.
116. Luker, G.D., Bardill, J.P,, Prior, C.M., Piwnica-Worms, D. and Leib, D.A. (2002) Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol, 76: 12149-12461.
117. Lycke, E., Johansson, M., Svennerholm, B. and Lindahl, U. (1991). Binding of herpes simplex virus to cellular heparan sulfate, an initial step in the adsorption process. J. Gen. Virol., 72: 1131-1137.
118. Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A. and Axel, R. (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell, 47: 333-348.
119. Mann, R., Mulligan, R.C., Baltimore, D. (1983) Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell, 33: 153-159.
120. Markert, J.M., Parker, J.N., Gillespie, G.Y. and Whitley, R,J. (2001). Genetically engineered human herpes simplex virus in the treatment of brain tumours. Herpes, 8: 17-22.
121. Maul, G.G., Ishov, A.M. and Everett, R.D. (1996). Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology, 217: 67-75.
122. McCarthy, A.M., McMahan, L. and Schaffer, P.A. (1989). Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol., 63: 18-27.
123. McGeoch, D.J., Dalrymple, M.A., Davison, A.J., Dolan, A., Frame, M.C., McNab, D., Perry, L.J., Scott, J.E. and Taylor, P. (1988). The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol., 69: 1531-1574.
124. Miller, A.D. and Buttimore, C. (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell Biol., 6: 2895-2902.
125. Miller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B. and Kieff, E. (1995) Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein- tyrosine kinases. Immunity, 2: 155-166.
126. Minson, A.C., Davison, A., Eberle, R., Desrosiers, R.C., Fleckenstein, B., McGeoch, D.J., Pellett, P.E., Roizman, B. and Studdert, M.J. (2000) Family Herpesviridae. In: Van Regenmortel, M.H.V., Fauquet, C.M., Bishop, D.H.L., Carstens, E.B., Estes, M.K., Lemon, S.M., Maniloff, J., Mayo, M.A., McGeoch, D.J., Pringle C.R. and Wickner, R.B. (Eds.), Virus Taxonomy, Academic Press, San Diego, pp. 203-225.
127. Miyoshi, H., Bloomer, U., Takahashi, M., Gage, F.H. and Verma, I.M. (1998) Development of a self-inactivating lentivirus vector. J. Virol., 72: 8150-8157.
128. Montgomery, R.I., Warner, M.S., Lum, B.J. and Spear, P.G. (1996). Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell, 87: 427-436.
129. Naldini, L. and Verma, I.M. (2000) Lentiviral vectors. Adv. Virus Res., 55: 599-609.
130. Naldini, L., Blomer, U., Gage, F.H., Trono, D. and Verma, I.M. (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA, 93: 11382-11388.
131. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M. and Trono. D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 272: 263-267.
132. Natsume, A., Matam, M., Wolfe, D., Oligino, T., Goss, J., Huang, S., Glorioso, J. and Fink, D.J. (2002). Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. J. Neurotrauma, 19: 61-68.
133. Nie, Z., Bergeron, D., Subbramanian, R.A., Yao, X.J., Checroune, F., Rougeau, N. and Cohen, E.A. (1998) The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol., 72:4104-4115.
134. Nonkwelo, C., Ruf, I. K. and Sample, J. (1997) The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element. J. Virol., 71:354-361.
135. Okubo, Y., Kakizawa, S., Hirose, K. and Iino, M. (2001) Visualization of IP(3) dynamics reveals a novel AMPA receptor-triggered IP(3) production pathway mediated by voltage-dependent Ca(2+) influx in Purkinje cells. Neuron, 32: 113-122.
136. Olivares, E.C., Hollis, R.P., Chalberg, t.W., Meuse, L., Kay, M.A. and Calos, M.P. (2002) Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol, 20: 1124-1128.
137. Olschowka, J.A., Bowers, W.J., Hurley, S.D., Mastrangelo, M.A. and Federoff, H.J. (2003) Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol. Ther., In press.
138. Patience, C., Takeuchi, Y., Cosset, F.L. and Weiss, R.A. (1998) Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells. J Virol, 72: 2671-2676.
139. Pawlik, T.M., Nakamura, H., Mullen, J.T., Kasuya, H., Yoon, S.S., Chandrasekhar, S., Chiocca, E.A. and Tanabe, K.K. (2002). Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene. Cancer, 95: 1171-1181.
140. Pereira, D.J., McCarty, D.M. and Muzyczka, N. (1997) The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J Virol, 71: 1079-1088.
141. Persichetti, F., Trettel, F., Huang, C.C., Fraefel, C., Timmers, H.T., Gusella, J.F. and MacDonald, M.E. (1999). Mutant huntingtin forms in vivo complexes with distinct context- dependent conformations of the polyglutamine segment. Neurobiol. Dis., 6 364-375.
142. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V. and Srivastava, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nature Med., 5: 71-77.
143. Qualtiere, L. F., Decoteau, J. F. and Hassan Nasr-el-Din, M. (1987) Epitope mapping of the major Epstein-Barr virus outer envelope glycoprotein gp350/220. J. Gen. Virol., 68: 535-543.
144. Rampling, R., Cruickshank, G., Papanastassiou, V., Nicoll, J., Hadley, D., Brennan, D., Petty, R., MacLean, A., Harland, J., McKie, E., Mabbs, R. and Brown, M. (2000) Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther., 7: 859-866.
145. Rees, R.C., McArdle, S., Mian, S., Li, G., Ahmad, M., Parkinson, R. and Ali, S.A. (2002). Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer. Curr. Opin. Mol. Ther., 4: 49-53.
146. Reisman, D., Yates, J. and Sugden, B. (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell Biol., 5 1822-1832.
147. Rizzuto, G., Gorgoni, B., Cappelletti, M., Lazzaro, D., Gloaguen, I., Poli, V., Sgura, A., Cimini, D., Ciliberto, G., Cortese, R., Fattori, E. and La Monica, N. (1999) Development of animal models for adeno-associated virus site-specific integration. J Virol, 73 2517-2526.
148. Rock, D.L., Nesburn, A.B., Ghiasi, H., Ong, J., Llewis, T.L., Lokensgard, J.R. and Wechsler, S.L. (1987). Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol., 62: 3820-3826.
149. Roizman, B. and Pellett, P.E. (2001) The family Herpesviridae: A brief introduction. In: Fields Virology, Knipe, D.M. and Howley, P.M. (Eds), Lippincott-Raven, Philadelphia, Pa., 4th edition, pp 2381-2397.
150. Roizman, B. and Sears, A.E. (1996). Herpes simplex viruses and their replication. In: Fields Virology, Fields, B.N., Knipe, D.M. and Howley, P.M. (Eds), Lippincott-Raven, Philadelphia, Pa., Vol. 2 (3rd edition), pp. 2231-2295.
151. Sadler, R. H. and Raab-Traub, N. (1995) The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat. J. Virol., 69: 4577-4581.
152. Saeki, Y., Ichikawa, T., Saeki, A., Chiocca, E.A., Tobler, K., Ackermann, M., Breakefield, X.O. and Fraefel, C. (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther., 9: 2787-2794.
153. Saeki, Y., Fraefel, C., Ichikawa, T., Breakefield, X.O. and Chiocca, E.A. (2001) Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther, 3: 591-601.
154. Saito, Y., Price, R.W., Rottenberg, D.A., Fox, J.J., Su, T.L., Watanabe, K.A. and Philips, F.S. (1982) Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science, 217: 1151-1153.
155. Samaniego, L.A., Neiderhiser, L. and DeLuca, N.A. (1998). Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol., 72: 3307-3320.
156. Samulski, R.J., Berns, K.I., Tan, M. and Muzyczka, N. (1982). Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA, 79: 2077-2081.
157. Samulski, R.J., Srivastava, A., Berns, K. I. and Muzyczka, N. (1983). Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell, 33: 135-143.
158. Samulski, R.J., Zhu, X., Xiao, X., Brook, J.D., Housman, D.E., Epstein, N. and Hunter, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J., 10: 3941-50.
159. Satoh, W., Hirai, Y., Tamayose, K. and Shimada, T. (2000) Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination. J Virol, 74: 10631-10638.
160. Savard, N., Cosset, F.-L. and Epstein, A.L. (1997) Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors. J. Virol. 71: 4111-4117.
161. Sawtell, N.M. and Thompson, R.L. (1992) Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 66: 2157-2169.
162. Schmidt, M., Afione, S. and Kotin, R.M. (2000) Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53. J. Virol., 74: 9441-9450.
163. Sciortino, M.T., Taddeo, B., Poon, A.P., Mastino, A. and Roizman, B. (2002) Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) mRNA to uninfected cells for expression prior to viral infection. Proc. Natl. Acad. Sci. USA, 99: 8318-8323.
164. Sclimenti, C.R., Thyagarajan, B. and Calos, M.P. (2001) Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res., 29: 5044-5051.
165. Sena-Esteves, M., Saeki, Y., Camp, S., Chiocca, E.A. and Breakefield, X.O. (1999) Single step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein Barr virus hybrid amplicons. J Virol, 73: 10426-10439.
166. Sena-Esteves, M., Saeki, Y., Fraefel, C. and Breakefield, X.O. (2000) HSV-1 amplicon vectors - simplicity and versatility. Mol Ther, 2: 9-15.
167. Sena-Esteves, M., Hampl, J.A., Camp, S.M. and Breakefield, X.O. (2002) Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors. J Gene Med, 4: 229-239.
168. Sena-Esteves, M., Camp, S., Bujard, H. and Breakefield, X.O. Self-contained tet-regulated amplicon vector, in preparation.
169. Severini, A., Scraba, D.G. and Tyrrell, D.L. (1996). Branched structures in the intracellular DNA of herpes simplex virus type 1. J. Virol., 70: 3169-3175.
170. Shieh, M-T., WuDunn, D., Montgomery, R.I., Esko, J.D. and Spear, P.G. (1992). Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol., 116: 1273-1281.
171. Simmons, G., Reeves, J. D., McKnight, A., Dejucq, N., Hibbitts, S., Power, C. A., Aarons, E., Schols, D., De Clercq, E., Proudfoot, A. E. and Clapham, P. R. (1998) CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J. Virol., 72: 8453-8457.
172. Smith, E. J., Brojatsch, J., Naughton, J. and Young, J. A. (1998) The CAR1 gene encoding a cellular receptor specific for subgroup B and D avian leukosis viruses maps to the chicken tvb locus. J. Virol. 72: 3501-3503.
173. Sodeik, B., Ebersold, M.W. and Helenius, A. (1997). Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol., 136: 1007-1021.
174. Sommerfelt, M. A., Williams, B. P., Clapham, P. R., Solomon, E., Goodfellow, P. N., Weiss, R. A. (1988) Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science, 242 1557-1559.
175. Sourvinos, G. and Everett, R. (2002). Visualization of parental HSV-1 genomes and replication compartments in association with ND10 in live infected cells. EMBO J., 21: 4989-4997.
176. Spaete, R.R. and Frenkel, N. (1982). The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell, 30: 295-304.
177. Stavropoulos, T.A. and Strathdee, C.A. (1998). An enhanced packaging system for helper-dependent herpes simplex virus vectors. J. Virol. 72: 7137-7143.
178. Steiner, I., Spivack, J.G., Lirette, R.P., Brown, S.M., MacLean, A.R., Subak-Sharpe, J.H. and Fraser, N.W. (1989) Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J., 8: 505-511.
179. Steven, A.C. and Spear, P.G. (1997). Herpesvirus capsid assembly and envelopment. In: Structural Biology of Viruses, Chiu, W., Burnett, R. and Garcea, R. (Eds), Oxford University Press, New York, pp. 312-351.
180. Stevens, J.G. (1975). Latent herpes simplex virus and the nervous system. Curr. Top. Microbiol. Immunol., 70: 31-50.
181. Stow, N.D. (1982). Localization of an origin of DNA replication in the TRs/IRs repeated region of the herpes simplex virus type 1 genome. EMBO J., 1: 863-867.
182. Summerford, C. and Samulski, R.J. (1998). Membrane-associated heparan sulfate proteo-glycan is a receptor for adeno-associated virus type 2 virions. J. Virol., 72: 1438-1445.
183. Summerford, C., Bartlett, J.S. and Samulski, R.J. (1999). AlphaVb5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nature Med., 5: 78-81.
184. Summerford, C., Bartlett, J.S. and Samulski, R.J. (2000). Adeno-associated viral vectors and successful gene therapy, the gap is closing. Gene Therapy and Regulation, 1: 9-32.
185. Suzuki, T., Yonekawa, H. and Ikeda, H. (1996) Localization of mouse homolog of the bovine leukemia virus receptor gene on mouse chromosome 10. Mamm. Genome, 7: 708-709.
186. Tailor, C. S., Nouri, A., Zhao, Y., Takeuchi, Y. and Kabat, D. (1999) A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J. Virol., 73: 4470-4474.
187. Takeuchi, Y., Vile, R. G., Simpson, G., O'Hara, B., Collins, M. K. and Weiss, R. A. (1992) Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J. Virol., 66: 1219-1222.
188. Tang, J., Yang, T., Ghosh, H.P. and Geller, A.I. (2001) Helper virus-free HSV-1 vectors packaged both in the presence of VSV G protein and in the absence of HSV-1 glycoprotein B support gene transfer into neurons in the rat striatum. J Neurovirol, 7: 548-555.
189. Terry-Allison, T., Montgomery, R.I., Whitbeck, C., Xu, R., Cohen, G.H., Eisenberg, R.J. and Spear, P.G. (1998). HveA (Herpesvirus Entry Mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J. Virol., 72: 5802-5810.
190. Thompson, R.L. and Sawtell, N.M. (1997) The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol., 71: 5432-5440.
191. Thorley-Lawson, D. A. and Edson, C. M. (1979) Polypeptides of the Epstein-Barr virus membrane antigen complex. J. Virol. 32 458-467.
192. Thyagarajan, B., Guimaraes, M.J., Groth, A.C. and Calos, M.P. (2000) Mammalian genomes contain active recombinase recognition sites. Gene, 244: 47-54.
193. Thyagarajan, B., Olivares, E.C., Hollis, R.P., Ginsburg, D.S. and Calos, M.P. (2001) Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol, 21: 3926-3934.
194. Tierney, R., Kirby, H., Nagra, J., Rickinson, A., Bell, A. (2000) The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5. J. Virol., 74: 10458-10467.
195. Tomkinson, B. and Kieff, E. (1992) Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection. J. Virol. 66: 780-789.
196. Tung, C.H., Mahmood, U., Bredow, S. and Weissleder, R. (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res, 60: 4953-4958.
197. Urcelay, E., Ward, P., Wiener, S.M., Safer, B. and Kotin, R.M. (1995). Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 69: 2038-2046.
198. Vigdal, T.J., Kaufman, C.D., Izsvak, Z., Voytas, D.F. and Ivics, Z. (2002) Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. J Mol Biol, 323: 441-452.
199. Vlazny, D.A., Kwong, A. and Frenkel, N. (1982). Site specific cleavage-packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA. Proc. Natl. Acad. Sci. USA, 79: 1423-1427.
200. von Schwedler, U., Kornbluth, R.S. and Trono, D. (1994) The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91: 6992-6996.
201. Vos, J.C., Baere, I. and Plasterk, R.H. (1996) Transposase is the only nematode protein required for in vitro transposition of Tc1. Genes Dev, 10: 755-761.
202. Wade-Martins, R., Frampton, J. and James, M.R. (1999) Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells. Nucleic Acids Res, 27: 1674-1682.
203. Wade-Martins, R., Smith, E.R., Tyminski, E., Chiocca, E.A. and Saeki, Y. (2001) An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat Biotechnol, 19 1067-1070.
204. Wagner, J.A., Nepomuceno, I.B,, Messner, A.H., Moran, M.L., Batson, E.P., Dimiceli, S., Brown, B.W., Desch, J.K., Norbash, A.M., Conrad, C.K., Guggino, W.B., Flotte, T.R., Wine, J.J., Carter, B.J., Reynolds, T.C., Moss, R.B. and Gardner, P. (2002). A Phase II, Double-Blind, Randomized, Placebo-Controlled Clinical Trial of tgAAVCF Using Maxillary Sinus Delivery in Patients with Cystic Fibrosis with Antrostomies. Hum. Gene Ther., 13: 1349-1359.
205. Wang, S. and Vos, J.-M. (1996) A hybrid herpes virus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J. Virol., 70: 8422-8430.
206. Wang, Y., Fraefel, C., Protasi, F., Moore, R.A., Fessenden, J.D,, Pessah, I.N., DiFrancesco, A., Breakefield, X. and Allen, P.D. (2000). HSV-1 amplicon vectors are a highly efficient gene delivery system for skeletal muscle myoblasts and myotubes. Am. J. Physiol. Cell Physiol., 278: C619-C626.
207. Wang, Y., Mukherjee, S., Fraefel, C., Breakefield, X.O. and Allen, P.D. (2002a). Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle. Hum. Gene Ther., 13: 261-273.
208. Wang, Y., Camp, S.M., Niwano, M., Shen, X., Bakowska, J.C., Breakefield, X.O. and Allen, P.D. (2002b) Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. J Virol, 76: 7150-7162.
209. Weitzman, M.D., Kyostio, S.R., Kotin, R.M. and Owens, R.A. (1994). Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA, 91: 5808-5812.
210. Westphal, E.M., Sierakowska, H., Livanos, E., Kole, R. and Vos, J.M. (1998) A system for shuttling 200-kb BAC/PAC clones into human cells: Stable extrachromosomal persistence and long-term ectopic gene activation. Hum. Gene Ther., 9:1863-1873.
211. Woisetschlaeger, M., Yandava, C. N., Furmanski, L. A., Strominger, J. L. and Speck, S. H. (1990) Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA, 87: 1725-1729.
212. Wybranietz, W.A., Gross, C.D., Phelan, A., O'Hare, P., Spiegel, M., Graepler, F., Bitzer, M., Stahler, P., Gregor, M. and Lauer, U.M. (2001) Enhanced suicide gene effect by adenovirus transduction of a VP22-cytosine deaminase (CD) fusion gene. Gene Ther., 8: 1654-1664.
213. Xiao, X., Li, J. and Samulski, R.J. (1998). Production of hight titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol., 72: 2224-2232.
214. Yang, Y. L., Guo, L., Xu, S., Holland, C. A., Kitamura, T., Hunter, K. and Cunningham, J. M. (1999) Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat. Genet., 21: 216-219.
215. Yant, S.R., Ehrhardt, A., Mikkelsen, J.G., Meuse, L., Pham, T. and M.A. (2002) Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat. Biotechnol., 20 999-1005.
216. York, I.A., Roop, C. andrews, D.W., Riddell, S.R., Graham, F.L. and Johnson, D.C. (1994) A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell, 77 525-535.
217. Young, S.M.J., McCarty, D.M., Degtyareva, N. and Samulski, R.J. (2000) Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J. Virol., 74: 3953-3966.
218. Young, S.M. Jr. and Samulski, R.J. (2001). Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc. Natl. Acad. Sci. USA, 98: 13525-13530.
219. Zhang, X., Efstathiou, S. and Simmons, A. (1994). Identification of novel herpes simplex virus replicative intermediates by field inversion gel electrophoresis: implications for viral DNA amplification strategies. Virology, 202: 530-539.
220. Zhang, H.G., Wang, Y.M., Xie, J.F., Liang, X., Hsu, H.C., Zhang, X., Douglas, J., Curiel, D.T. and Mountz, J.D. (2001). Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus. Gene Ther., 8: 704-712.
221. Zhou, X. and Muzyczka, N. (1998). In vitro packaging of adeno-associated virus DNA. J. Virol., 72: 3241-3247.
222. Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T.J., Chiodo, V.A., Phillipsberg, T., Muzyczka, N., Hauswirth, W.W., Flotte, T.R., Byrne, B.J. and Snyder, R.O. (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods, 28: 158-167.